• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

  • Print
  • Share
  • E-mail
  • en Español en Español
?
-

Small Business Assistance

 

Tobacco Product Review and Evaluation Pathways

FDA has created a new section on our website to provide information about the criteria for review and evaluation of new and modified risk tobacco products, before they are marketed, to determine their impact on public health.  FDA created the Tobacco Product Review and Evaluation content to provide:

  • Centralized information on the three pathways to legally market new tobacco products;
  • An interactive tool to provide greater understanding about which pathway may be appropriate for a new tobacco product; and
  • Information on how to legally market a tobacco product with an explicit or implicit modified risk claim.

Visit the Tobacco Product Review and Evaluation page to learn more. 

 


 

Tobacco Product Manufacturing Facility Visits

The Tobacco Product Manufacturing Facility Visits program is intended to give FDA staff an opportunity to:

  • visit facilities involved in the manufacturing of tobacco products, including any related laboratory testing,
  • observe the manufacturing operations of the tobacco industry – from the receipt of raw materials to the distribution of finished products, and
  • learn about the manufacturing practices and processes unique to regulated tobacco products and their facilities.

These tours are educational in nature and are not intended to include or replace official FDA inspections of facilities. 

Participate in the Program!

If you are interested in participating in this program, please submit a request for participation via the Federal Register Notice Docket No. FDA-2012-N-0853

 

Final Rule: Substantial Equivalence Exemption

On July 1, 2011, FDA issued a final rule  to establish procedures for requesting an exemption from the substantial equivalence requirements of the Food, Drug, & Cosmetic Act. Exemptions from demonstrating substantial equivalence are limited to modifications of additive levels.

 

Cigarette Health Warnings

On June 21, 2011, FDA issued the regulation that will require cigarette health warnings on packaging and advertisements. There are different requirements and compliance dates based on whether you are a tobacco product manufacturer, retailer, importer, or distributor.

Cigarette Health Warnings: What Small Businesses Need to Know

 

Sale and Distribution 

Who is covered, or impacted, by the Youth Access and Advertising regulations?
The regulations apply to manufacturers, distributors, importers, retailers, and others who sell cigarettes and/or smokeless tobacco.

 

Registration and Product Listing

Guidance for Industry: Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments

  

Rotational Warning Plans

Guidance for Industry: Enforcement Policy Concerning Rotational Warning Plans for Smokeless Tobacco Products

  

Low, Light and Mild or Similar Descriptors

Guidance for Industry and FDA Staff: Use of “Light,” “Mild,” “Low,” or Similar Descriptors in the Label, Labeling, or Advertising of Tobacco Products

 

Listing of Ingredients in Tobacco Products

Final Guidance for Industry: Listing of Ingredients in Tobacco Products 

 

Tobacco Health Document Submission

 

 

-
-